Heterologous prime-boost strategies in the development of novel vaccines against leishmaniasis

Heterologous prime-boost strategies in the development of novel vaccines against leishmaniasis

Bibliographic Details
Main Author:	Lange, Uta Gisela
Published:	University of Cambridge 2003
Subjects:	610
Online Access:	http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.619876

Similar Items

Heterologous prime-boost vaccine regimens against Chlamydia trachomatis
by: Badamchi-Zadeh, Alexander
Published: (2014)

Heterologous prime-boost: an important candidate immunization strategy against Tembusu virus
by: Yuting Pan, et al.
Published: (2020-05-01)

Characterisation of heterologous prime-boost vaccination strategies : an investigation into the nature and delivery of vaccines and the subsequent generation of immune responses
by: Searle, Benjamin James
Published: (2004)

Sterile protection against Plasmodium knowlesi in rhesus monkeys from a malaria vaccine: comparison of heterologous prime boost strategies.
by: George Jiang, et al.
Published: (2009-08-01)

Exploring heterologous prime-boost vaccination approaches to enhance influenza control in pigs
by: Chong Li, et al.
Published: (2020-07-01)

Development of novel prime-boost strategies based on a tri-gene fusion recombinant L. tarentolae vaccine against experimental murine visceral leishmaniasis.
by: Noushin Saljoughian, et al.
Published: (2013-01-01)

Mucosal Heterologous Prime/Boost Vaccination Induces Polyfunctional Systemic Immunity, Improving Protection Against Trypanosoma cruzi
by: Andrés Sanchez Alberti, et al.
Published: (2020-02-01)

Heterologous vaccine interventions: boosting immunity against future pandemics
by: Daniela Marín-Hernández, et al.
Published: (2021-05-01)

Heterologous Prime-Boost HIV-1 Vaccination Regimens in Pre-Clinical and Clinical Trials
by: Julia L. Hurwitz, et al.
Published: (2010-02-01)

Heterologous Prime Boost Vaccination Induces Protective Melanoma-Specific CD8+ T Cell Responses
by: Sandra S. Ring, et al.
Published: (2020-12-01)

Accelerated heterologous prime-boost adenovirus vector-based SIV vaccine in neonatal rhesus monkeys
by: Liu J, et al.
Published: (2012-09-01)

Heterologous Prime-Boost Vaccination Enhances TsPmy’s Protective Immunity against Trichinella spiralis Infection in a Murine Model
by: Lei Wang, et al.
Published: (2017-07-01)

Heterologous Prime-Boost Combinations Highlight the Crucial Role of Adjuvant in Priming the Immune System
by: Annalisa Ciabattini, et al.
Published: (2018-03-01)

Enhanced immune response against HIV-1 induced by a heterologous DNA prime-adenovirus boost vaccination using mannosylated polyethyleneimine as DNA vaccine adjuvant
by: Li M, et al.
Published: (2013-05-01)

P19-55 LB. Effective control of a pathogenic SIVmac239 challenge by a novel heterologous mucosal prime and intramuscular boost vaccine strategy
by: Zhang L, et al.
Published: (2009-10-01)

A Heterologous Multiepitope DNA Prime/Recombinant Protein Boost Immunisation Strategy for the Development of an Antiserum against Micrurus corallinus (Coral Snake) Venom.
by: Henrique Roman Ramos, et al.
Published: (2016-03-01)

Ad35.CS.01-RTS,S/AS01 Heterologous Prime Boost Vaccine Efficacy against Sporozoite Challenge in Healthy Malaria-Naïve Adults.
by: Christian F Ockenhouse, et al.
Published: (2015-01-01)

LFA-1 Mediates Cytotoxicity and Tissue Migration of Specific CD8+ T Cells after Heterologous Prime-Boost Vaccination against Trypanosoma cruzi Infection
by: Camila Pontes Ferreira, et al.
Published: (2017-10-01)

Comparison of Heterologous Prime-Boost Strategies against Human Immunodeficiency Virus Type 1 Gag Using Negative Stranded RNA Viruses.
by: Tessa M Lawrence, et al.
Published: (2013-01-01)

Broad Protection of Pigs against Heterologous PRRSV Strains by a GP5-Mosaic DNA Vaccine Prime/GP5-Mosaic rVaccinia (VACV) Vaccine Boost
by: Junru Cui, et al.
Published: (2020-02-01)

Multiserotype protection elicited by a combinatorial prime-boost vaccination strategy against bluetongue virus.
by: Eva Calvo-Pinilla, et al.
Published: (2012-01-01)

Electroporation as a "prime/boost" strategy for naked DNA vaccination against a tumor antigen
by: Buchan, Sarah, et al.
Published: (2005)

Preferential targeting of conserved Gag regions after vaccination with a heterologous DNA prime Modified Vaccinia Ankara boost HIV vaccine regime
by: Bauer A, et al.
Published: (2012-09-01)

Determination of optimal prime-boost vaccination regimens against zaire ebolavirus
by: Aviles, Jenna
Published: (2013)

Determination of optimal prime-boost vaccination regimens against zaire ebolavirus
by: Aviles, Jenna
Published: (2013)

Relevance of long-lived CD8+ T effector memory (TEM) cells for protective immunity elicited by heterologous prime-boost vaccination.
by: José Ronnie Vasconcelos, et al.
Published: (2012-12-01)

Heterologous Boosting With Listeria-Based Recombinant Strains in BCG-Primed Mice Improved Protection Against Pulmonary Mycobacterial Infection
by: Si-Jing Liu, et al.
Published: (2020-09-01)

Priming with a “simplified regimen” of HIV-1 DNA vaccine is as good as a “standard regimen” when boosted with heterologous HIV-1 MVA vaccine
by: Munseri P, et al.
Published: (2012-09-01)

Superior neutralizing antibody response and protection in mice vaccinated with heterologous DNA prime and virus like particle boost against HPAI H5N1 virus.
by: Heng Ding, et al.
Published: (2011-01-01)

TLR1/2 activation during heterologous prime-boost vaccination (DNA-MVA) enhances CD8+ T Cell responses providing protection against Leishmania (Viannia).
by: Asha Jayakumar, et al.
Published: (2011-06-01)

Can Complementary Prime-Boost Immunization Strategies Be an Alternative and Promising Vaccine Approach Against Dengue Virus?
by: Iris Valdés, et al.
Published: (2019-08-01)

Informing development strategies for new tuberculosis vaccines : mathematical modelling and novel epidemiological tools
by: Harris, R. C.
Published: (2018)

Novel intranasal GNRs-DNA vaccines against human papillomavirus infection
by: Li, Wenqin
Published: (2015)

Efficacy of Heterologous Prime-Boost Vaccination with H3N2 Influenza Viruses in Pre-Immune Individuals: Studies in the Pig Model
by: Sharon Chepkwony, et al.
Published: (2020-09-01)

Heterologous prime-boost vaccination with H3N2 influenza viruses of swine favors cross-clade antibody responses and protection
by: Kristien Van Reeth, et al.
Published: (2017-04-01)

Heterologous Ad26.COV2.S Prime and mRNA-Based Boost COVID-19 Vaccination Regimens: The SWITCH Trial Protocol
by: Roos S. G. Sablerolles, et al.
Published: (2021-09-01)

Searching for an HIV Vaccine: A Heterologous Prime-boost System using Replicating Vaccinia Virus and Plant-produced Virus-like Particles
Published: (2016)

Prime-boost Immunization Strategies against Dengue Virus (DENV)
by: Chung-Yu Yang, et al.
Published: (2015)

Heterologous prime-boost vaccination with DNA and MVA vaccines, expressing HIV-1 subtype C mosaic Gag virus-like particles, is highly immunogenic in mice.
by: Ros Chapman, et al.
Published: (2017-01-01)

Novel Prophylactic Vaccine Using a Prime-Boost Method and Hemagglutinating Virus of Japan-Envelope against Tuberculosis
by: Masaji Okada, et al.
Published: (2011-01-01)

Cannot write session to /tmp/vufind_sessions/sess_04pddossp5q7gilev4htgcjfl4